Dahham Alsoud

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Palliative Care

Patient Reported Outcomes

Top Venues

Inflammatory bowel diseases

Therapeutic drug monitoring

Journal of Crohn's & colitis

The American journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Ben Van Calster
Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease. Inflammatory bowel diseases (2024)
Dahham Alsoud, João Sabino, Denis Franchimont, Anneline Cremer, Julie Busschaert, François D'Heygere, Peter Bossuyt, Anne Vijverman, Séverine Vermeire, Marc Ferrante
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study. Inflammatory bowel diseases (2024)
Dahham Alsoud, Bram Verstockt, Severine Vermeire
Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics. Inflammatory bowel diseases (2024)
Dahham Alsoud, Bram Verstockt, Severine Vermeire
Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics. Inflammatory bowel diseases 30 (5) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Ben Van Calster
Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease. Inflammatory bowel diseases 30 (6) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring (2024)
Dahham Alsoud, Jessica Ho, Bram Verstockt
The Serum-Based Endoscopic Healing Index Can Monitor Therapeutic Response in Crohn's Disease. Journal of Crohn's & colitis (2023)
Dahham Alsoud, Jessica Ho, João Sabino, Marc Ferrante, Séverine Vermeire, Bram Verstockt
Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis. The American journal of gastroenterology (2023)
Dahham Alsoud, Gert De Hertogh, Griet Compernolle, Sophie Tops, João Sabino, Marc Ferrante, Debby Thomas, Severine Vermeire, Bram Verstockt
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis. Journal of Crohn's & colitis 16 (10) (2022)
Dahham Alsoud, Bram Verstockt, Séverine Vermeire
Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era. Alimentary pharmacology & therapeutics 55 (7) (2022)